The role of Gefitinib in patients with non-small-cell lung cancer in India-Reference-Cited by-同舟云学术

The role of Gefitinib in patients with non-small-cell lung cancer in India

Published:2013 Issue:1 Volume:19 Page:48
ISSN:0973-1075
Container-title:Indian Journal of Palliative Care
language:en
Short-container-title:Indian J Palliat Care

Author:

Mehta AsmitaAnilkumar,Jose WesleyM,Pavithran Kicheelath,Triavadi GanesanS

Publisher

Scientific Scholar

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference36 articles.

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, Version 2.0., Lyon: IARC Press; 2004.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Variants in the ABCB1 and ABCG2 Gene Drug Transporters Involved in Gefitinib-Associated Adverse Reaction: A Systematic Review and Meta-Analysis;Genes;2024-05-07

2. Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches;International Journal of Nanomedicine;2023-12

3. Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials;Recent Patents on Anti-Cancer Drug Discovery;2023-11

4. Crizotinib, an Effective Agent in ROS1-Rearranged Adenocarcinoma of Lungs: A Case Report;Clinical Medicine Insights: Case Reports;2018-01-01

5. Complete response to afatinib in lung adenocarcinoma of epidermal growth factor receptor exon-19 deletion mutation and disease recurrence on drug discontinuation;Journal of Pharmacology and Pharmacotherapeutics;2018